71st Congress of the Italian Embryological Group-Italian Society of Development and Cell Biology (GEI-SIBSC)

60 | CELLULAR DYSHOMEOSTASIS AND REDOX IMBALANCE INDUCED BY CANTHARIDIN IN GLIOBLASTOMA MODELS

R. Proietti, V. D’Ezio, A. Presaghi, L. Salsedo, A. Sperati, M.A. Bologna, M. Colasanti, T. Persichini | Dept. of Science, Roma Tre University, Rome, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 June 2026
0
Views
0
Downloads

Authors

Cantharidin (CTD), a toxic terpene derived from Meloidae beetles, has historically been shown to possess various therapeutic properties, including potential anti-tumor activity1. This study investigated the cellular uptake of CTD and its impact on the redox defense system in U373 glioblastoma cells.
Using the Parallel Artificial Membrane Permeability Assay, we first evaluated the entry mechanism of this molecule. The results showed that CTD can cross biological membranes via passive diffusion, independent of protein transporters.
Treatment with CTD induced a significant, time-dependent increase in reactive oxygen species (ROS) levels, peaking at 6 h. RT-qPCR and Western Blot analyses revealed that while the cystine transporter xCT and Heme Oxygenase-1 (HO-1) levels were strongly increased, the peroxide-scavenging enzymes catalase and GPX4 were not upregulated, showing a heterogeneous antioxidant response.
These findings are linked to the role of Nrf2, the main transcription factor orchestrating the antioxidant response2. Indeed, CTD treatment caused a 50-60% reduction in its nuclear levels. Notably, CTD prevented Nrf2 accumulation even in the presence of its activator, dimethyl fumarate. As Nrf2 mRNA levels remained unchanged, we hypothesized that the inhibitory effect occurs at the post-translational level, likely affecting nuclear trafficking dynamics.
Finally, we investigated the causal link between oxidative stress and cell death. Although the antioxidant N-acetylcysteine successfully neutralized ROS and restored the baseline levels of xCT and HO-1, it only partially restored cell viability. These findings suggest that while CTD disrupts redox balance and inhibits Nrf2-mediated defenses, oxidative stress is not the primary driver of its toxicity. Therefore, further studies are needed to improve our understanding of the pathways underlying the cytotoxic action of CTD.
Acknowledgments: This work was supported by the Rome Technopole PNRR grant (CUP F83B22000040006).

Downloads

Download data is not yet available.

Citations

1. Scott KA [et al.]. [Titolo dell’articolo non disponibile]. RSC Med Chem. 2025;17:743-767. DOI: https://doi.org/10.1039/D5MD00917K
2. Baxter PS, Hardingham GE. Adaptive regulation of the brain’s antioxidant defences by neurons and astrocytes. Free Radic Biol Med. 2016 Nov;100:147-152. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.06.027

How to Cite



1.
DELLO SVILUPPO E DELLA CELLULA G-SIDB. 60 | CELLULAR DYSHOMEOSTASIS AND REDOX IMBALANCE INDUCED BY CANTHARIDIN IN GLIOBLASTOMA MODELS: R. Proietti, V. D’Ezio, A. Presaghi, L. Salsedo, A. Sperati, M.A. Bologna, M. Colasanti, T. Persichini | Dept. of Science, Roma Tre University, Rome, Italy. Eur J Histochem [Internet]. 2026 Jun. 22 [cited 2026 Jun. 23];70(s1). Available from: https://www.ejh.it/ejh/article/view/4678